In the in vitro study, we used the siRNA-CD147 to block the interactions between CyPA and CD147 selectively and observed the attenuation of EMT and renal fibrosis, which was consistent with other studies and our in vivo study. The gene discussed is PPIA; the disease is renal fibrosis.